Creatinine Sensing with Reduced Graphene Oxide-Based Field Effect Transistors

Creatinine (Crn) is a clinically relevant biomarker commonly used for the diagnosis and monitoring of kidney disease. In this work, we report the fabrication of reduced-graphene-oxide-based field-effect transistors (rGO FETs) for Crn detection. These devices were functionalized using a layer-by-layer (LbL) assembly, in which polyethyleneimine (PEI) and creatinine deiminase (CD) were alternately deposited. This LbL strategy allows for the effective incorporation of CD without compromising its structural or functional integrity, while also taking advantage of the local pH changes caused by creatinine hydrolysis. It also benefits from the use of a polyelectrolyte that can amplify the enzymatic signal. Furthermore, it enables scalable and efficient fabrication. These transistors also address the challenges of point-of-care implementation in single-use cartridges. It is worth noting that the devices showed a linear relationship between the Dirac-point shift and the logarithm of the creatinine concentration in the 20–500 µM range in diluted simulated urine. The sensor response improved with increasing numbers of PEI/CD bilayers. Furthermore, the functionalized FETs demonstrated rapid detection dynamics and good long-term stability. Present results confirm the potential of these devices as practical biosensors for sample analysis under real-world conditions, making them ideal for implementation in practical settings.